Hiroyuki Nomura

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 12

Top Venues

Journal of gynecologic oncology

Cancer medicine

Molecules (Basel, Switzerland)

International journal of clinical oncology

Fujita Health University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Fujita Health University Apr 01 2019

Japan

Associate Professor :: Obstetrics and Gynecology

Publications

Yosuke Konno, Michinori Mayama, Kazuhiro Takehara, Yoshihito Yokoyama, Jiro Suzuki, Nobuyuki Susumu, Kenichi Harano, Satoshi Nakagawa, Toru Nakanishi, Wataru Yamagami, Kosuke Yoshihara, Hiroyuki Nomura, Aikou Okamoto, Daisuke Aoki, Hidemichi Watari
Prognostic impact of the number of resected pelvic nodes in endometrial cancer: Japanese Gynecologic Oncology Group Study JGOG2043 post hoc analysis. Journal of gynecologic oncology (2024)
Muneaki Shimada, Kosuke Yoshihara, Terumi Tanigawa, Hiroyuki Nomura, Junzo Hamanishi, Satoe Fujiwara, Hiroshi Tanabe, Hiroaki Kajiyama, Masaki Mandai, Daisuke Aoki, Takayuki Enomoto, Aikou Okamoto
An attempt to establish real-world databases of poly(ADP-ribose) polymerase inhibitors for advanced or recurrent epithelial ovarian cancer: the Japanese Gynecologic Oncology Group. Journal of gynecologic oncology 34 (3) (2023)
Muneaki Shimada, Kosuke Yoshihara, Terumi Tanigawa, Hiroyuki Nomura, Junzo Hamanishi, Satoe Fujiwara, Hiroshi Tanabe, Hiroaki Kajiyama, Masaki Mandai, Daisuke Aoki, Takayuki Enomoto, Aikou Okamoto
An attempt to establish real-world databases of poly(ADP-ribose) polymerase inhibitors for advanced or recurrent epithelial ovarian cancer: the Japanese Gynecologic Oncology Group. Journal of gynecologic oncology 34 (3) (2023)
Muneaki Shimada, Kosuke Yoshihara, Terumi Tanigawa, Hiroyuki Nomura, Junzo Hamanishi, Satoe Fujiwara, Hiroshi Tanabe, Hiroaki Kajiyama, Masaki Mandai, Daisuke Aoki, Takayuki Enomoto, Aikou Okamoto
An attempt to establish real-world databases of poly(ADP-ribose) polymerase inhibitors for advanced or recurrent epithelial ovarian cancer: the Japanese Gynecologic Oncology Group. Journal of gynecologic oncology 34 (3) (2023)
Muneaki Shimada, Kosuke Yoshihara, Terumi Tanigawa, Hiroyuki Nomura, Junzo Hamanishi, Satoe Fujiwara, Hiroshi Tanabe, Hiroaki Kajiyama, Masaki Mandai, Daisuke Aoki, Takayuki Enomoto, Aikou Okamoto
An attempt to establish real-world databases of poly(ADP-ribose) polymerase inhibitors for advanced or recurrent epithelial ovarian cancer: the Japanese Gynecologic Oncology Group. Journal of gynecologic oncology (2023)
Muneaki Shimada, Kosuke Yoshihara, Terumi Tanigawa, Hiroyuki Nomura, Junzo Hamanishi, Satoe Fujiwara, Hiroshi Tanabe, Hiroaki Kajiyama, Masaki Mandai, Daisuke Aoki, Takayuki Enomoto, Aikou Okamoto
An attempt to establish real-world databases of poly(ADP-ribose) polymerase inhibitors for advanced or recurrent epithelial ovarian cancer: the Japanese Gynecologic Oncology Group. Journal of gynecologic oncology 34 (3) (2023)
Muneaki Shimada, Kosuke Yoshihara, Terumi Tanigawa, Hiroyuki Nomura, Junzo Hamanishi, Satoe Fujiwara, Hiroshi Tanabe, Hiroaki Kajiyama, Masaki Mandai, Daisuke Aoki, Takayuki Enomoto, Aikou Okamoto
An attempt to establish real-world databases of poly(ADP-ribose) polymerase inhibitors for advanced or recurrent epithelial ovarian cancer: the Japanese Gynecologic Oncology Group. Journal of gynecologic oncology 34 (3) (2023)
Masayuki Sekine, Takayuki Enomoto, Masami Arai, Hiroki DEN, Hiroyuki Nomura, Takeshi Ikeuchi, Seigo Nakamura, null null
Differences in age at diagnosis of ovarian cancer for each BRCA mutation type in Japan: optimal timing to carry out risk-reducing salpingo-oophorectomy. Journal of gynecologic oncology 33 (4) (2022)
Naomi Iwasa-Inoue, Hiroyuki Nomura, Fumio Kataoka, Tatsuyuki Chiyoda, Tomoko Yoshihama, Yoshiko Nanki, Kensuke Sakai, Yusuke Kobayashi, Wataru Yamagami, Tohru Morisada, Akira Hirasawa, Daisuke Aoki
Prospective feasibility study of neoadjuvant dose-dense paclitaxel plus carboplatin with bevacizumab therapy followed by interval debulking surgery for advanced ovarian, fallopian tube, and primary peritoneal cancer patients. International journal of clinical oncology (2021)
Yutaka Tamada, Hiroyuki Nomura, Daisuke Aoki, Tatsuro Irimura
A Possible Inhibitory Role of Sialic Acid on MUC1 in Peritoneal Dissemination of Clear Cell-Type Ovarian Cancer Cells. Molecules (Basel, Switzerland) 26 (19) (2021)
Keiko Saotome, Tatsuyuki Chiyoda, Eriko Aimono, Kohei Nakamura, Shigeki Tanishima, Sachio Nohara, Chihiro Okada, Hideyuki Hayashi, Yuka Kuroda, Hiroyuki Nomura, Nobuyuki Susumu, Takashi Iwata, Wataru Yamagami, Fumio Kataoka, Hiroshi Nishihara, Daisuke Aoki
Clinical implications of next-generation sequencing-based panel tests for malignant ovarian tumors. Cancer medicine 9 (20) (2020)
Wataru Yamagami, Nobuyuki Susumu, Takeshi Makabe, Kensuke Sakai, Hiroyuki Nomura, Fumio Kataoka, Akira Hiraswa, Kouji Banno, Daisuke Aoki
Is repeated high-dose medroxyprogesterone acetate (MPA) therapy permissible for patients with early stage endometrial cancer or atypical endometrial hyperplasia who desire preserving fertility? Journal of gynecologic oncology 29 (2) (2018)

Hiroyuki Nomura.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Hiroyuki Nomura